Skip to main content
EDSA logo

Edesa Biotech, Inc.

EDSANASDAQHealthcareBiotechnology

$2.77Today:- (-)1Y +2.60%

As of Oct 23, 2026 close

Market cap
$24.95M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.72$20.32
Volume (live)
-
Avg. volume (3M)
42.85K

Edesa Biotech (EDSA) Financial Ratios

For fiscal 2025 (fiscal year ended Sep 30, 2025), Edesa Biotech had return on equity of -99.6% (up from -136.7%), a current ratio of 10.68 (up from 0.91) and return on assets of -57.0% (up from -69.0%). A current ratio of 10.68 means current assets exceed current liabilities.

Edesa Biotech Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income StatementBalance SheetCash FlowRatios
Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2012FY 2011
Period endingSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Aug 2012Aug 2011
Valuation Ratios
P/E Ratio------8330.00-18293.30
Forward P/E0.880.880.8856.67---
P/S Ratio-----3238.67-
P/B Ratio1.407.291.891.527.491074.14-
Price/Tangible Book14.32-2.742.009.1650734.9420023.40
Price/FCF------230.10-
Price/OCF------234.67-
Enterprise Value Ratios
EV/Revenue-----3235.13-
EV/EBITDA------154.91-
EV/EBIT------152.05-
EV/FCF------229.85-
Profitability & Returns
Return on Equity (ROE)-99.57%-136.66%-101.88%-156.34%-120.39%-260.21%-114.87%
Return on Assets (ROA)-57.02%-69.02%-56.33%-87.78%-116.79%-189.66%-78.74%
Return on Invested Capital (ROIC)------2145.31%-838.71%
Return on Capital Employed (ROCE)-63.50%-354.10%-130.50%-194.70%-180.40%-214.04%-81.45%
Leverage & Solvency Ratios
Debt/Equity-0.010.010.000.01--
Liquidity Ratios
Current Ratio10.680.913.534.258.291.8626.53
Quick Ratio10.600.713.293.907.641.8126.30
Efficiency Ratios
Asset Turnover-----0.090.14
Yield & Distribution Ratios
Earnings Yield-41.34%-42.70%-62.82%-123.19%-13.64%-0.01%-0.01%
FCF Yield-42.12%-33.84%-49.78%-86.24%-13.98%-0.43%-
Buyback Yield-77.54%-11.84%-36.37%-21.50%-40.32%-14.93%-
Total Return------14.93%-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Edesa Biotech Financial Ratios

What is Edesa Biotech's return on equity?

Edesa Biotech's return on equity (ROE) was -99.6% for fiscal 2025 (period ended Sep 30, 2025). It was -136.7% a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition